GlassScriptPhysician profile
John R Vann
NPI 1326415050
$9,024.57
in general payments reported to CMS, 2019-2025
34 companies · $2,956 in 2025
The $2,956 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $780 · 2021: $1,536 · 2022: $945 · 2023: $785 · 2024: $1,387 · 2025: $2,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,791 · Travel and Lodging: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,790.50 |
| Travel and Lodging | $1,337.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,423.60 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Navitor |
| Novartis Pharmaceuticals Corporation | $793.48 | 2021-2025 | |
| Abiomed | $678.61 | 2023-2025 | Impella |
| Amgen INC. | $327.54 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $298.59 | 2019-2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $277.58 | 2019-2025 | Andexxa, Farxiga, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $210.33 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $196.33 | 2021-2025 | Camzyos, Eliquis |
| Penumbra, INC. | $164.91 | 2025 | Indigo System |
| Actelion Pharmaceuticals US, INC. | $154.76 | 2022 | |
| Merck Sharp & Dohme LLC | $154.65 | 2022-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $147.38 | 2019-2024 | |
| Inari Medical, INC. | $106.65 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $99.95 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.00 | 2022-2023 | Jardiance |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $91.62 | 2025 | Pascal |
| Philips North America LLC | $90.91 | 2022-2024 | (Ck4) Mcot |
| Esperion Therapeutics, INC. | $75.74 | 2022-2024 | Nexletol |
| Alnylam Pharmaceuticals INC. | $75.39 | 2025 | Onpattro, Amvuttra |
| Medtronic Vascular, INC. | $73.77 | 2020 | |
| Janssen Pharmaceuticals, INC | $73.05 | 2021-2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $67.95 | 2023-2024 | Inpefa |
| Cvrx, INC. | $53.34 | 2024-2025 | Barostim Neo System |
| Novo Nordisk INC | $48.76 | 2022-2023 | Ozempic, Rybelsus |
| Angiodynamics, INC. | $38.88 | 2025 | Alphavac |
| Bayer Healthcare Pharmaceuticals INC. | $35.47 | 2025 | |
| Medtronic, INC. | $32.11 | 2021 | |
| Chiesi USA, INC. | $29.63 | 2023-2024 | Kengreal, Cleviprex |
| Impulse Dynamics (USA) INC. | $21.49 | 2023 | Optimizer |
| Baxter Healthcare | $20.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Cardiac Dimensions, INC. | $18.90 | 2024 | |
| Silk Road Medical, INC. | $18.74 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bridgebio Pharma, INC. | $16.30 | 2025 | Attruby |
| Lilly USA, LLC | $16.10 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Vann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.